Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Winter, Jane N.
Professor
Bio
Winter's clinical and research interests focus on the malignant lymphomas (both Hodgkin and non-Hodgkin), particularly the development of novel therapies and the investigation of clinical and biologic... [more]
Yue, Feng
Professor
Bio
The long-term goal of Dr. Yue's group is to use a combination of high throughput genomics, computational modeling, and functional assays to study how genetic variants contribute to the pathogenes... [more]
Zhou, Alan (Xiaolong)
Assistant Professor
Bio
My goal is to use dermatology as a platform for studying and advancing genetics, immunology, and cancer biology. I have been fortunate to have a strong background in immunology, genetics and cell biol... [more]